SMSLIFE — SMS Lifesciences India Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹2.19bn
- IN₹3.40bn
- IN₹3.16bn
- 54
- 28
- 85
- 58
Annual cashflow statement for SMS Lifesciences India, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 254 | 147 | 196 | 200 | 142 |
| Depreciation | |||||
| Non-Cash Items | 29.6 | 33.7 | 25.1 | 36.2 | 47 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -47.4 | -114 | 52.3 | -449 | -150 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 300 | 145 | 352 | -112 | 147 |
| Capital Expenditures | -244 | -234 | -356 | -512 | -486 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -196 | -36.7 | 93.2 | 440 | 173 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -440 | -270 | -262 | -71.4 | -313 |
| Financing Cash Flow Items | -21.9 | -30.9 | -25.2 | -35.4 | -35.3 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 154 | 124 | -25.5 | 108 | 169 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 13.5 | -0.27 | 63.9 | -75.5 | 2.92 |